Literature DB >> 14687032

Decrease of Smad4 gene expression in patients with essential thrombocythaemia may cause an escape from suppression of megakaryopoiesis by transforming growth factor-beta1.

Hiroyuki Kuroda1, Takuya Matsunaga, Takeshi Terui, Ikuta Tanaka, Rishu Takimoto, Koshi Fujikawa, Tetsuji Takayama, Junji Kato, Yasuo Hirayama, Sumio Sakamaki, Kyuhei Kohda, Yoshiro Niitsu.   

Abstract

Essential thrombocythaemia (ET) is characterized by the abnormal and sustained proliferation of megakaryocytes. The mechanism for this lineage-specific expansion in ET, remains unclear. We have previously reported that transforming growth factor-beta1 (TGF-beta1) is involved in negative feedback regulation of megakaryopoiesis in both healthy volunteers (HV) and patients with idiopathic thrombocytopenic purpura (ITP). The present study found that megakaryocyte colony-forming units (CFU-MK) of ET patients were less sensitive to TGF-beta1 than those of HV. The expression of Smad4 (Sma- and Mad-related protein-4) in CFU-MK of ET patients was reduced in comparison with that of HV. Finally, to confirm that the impaired TGF-beta1 sensitivity was caused by reduced expression of Smad4, we examined Smad4-transfected CFU-MK from ET patients in the presence of TGF-beta1, and verified that the transfectants were indeed as susceptible as CFU-MK from HV to TGF-beta1. Thus it was surmised that one of the mechanisms for impaired sensitivity of CFU-MK to TGF-beta1 is the reduced expression of Smad4.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687032     DOI: 10.1046/j.1365-2141.2003.04755.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

Review 1.  Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β.

Authors:  Archana Agarwal; Kerry Morrone; Matthias Bartenstein; Zhizhuang Joe Zhao; Amit Verma; Swati Goel
Journal:  Stem Cell Investig       Date:  2016-02-26

2.  Henoch-Schonlein Purpura with thrombocythaemia: an abnormality in Smad4 expression?

Authors:  Joshua M Brostoff; Gopinath M Ranganna; C Bernard Colaco
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 2.631

3.  The relationship of the active and latent forms of TGF-β1 with marrow fibrosis in essential thrombocythemia and primary myelofibrosis.

Authors:  Cesar Cilento Ponce; Maria de Lourdes F Chauffaille; Silvia Saiuli M Ihara; Maria Regina R Silva
Journal:  Med Oncol       Date:  2011-12-27       Impact factor: 3.064

Review 4.  Role of transforming growth factor-beta in hematologic malignancies.

Authors:  Mei Dong; Gerard C Blobe
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

5.  Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.

Authors:  Guo-Zhong Ji; Xue-Hao Wang; Lin Miao; Zheng Liu; Ping Zhang; Fa-Ming Zhang; Jian-Bing Yang
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

6.  Involvement of TGFβ1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis.

Authors:  Stefania Badalucco; Christian Andrea Di Buduo; Rita Campanelli; Isabella Pallotta; Paolo Catarsi; Vittorio Rosti; David L Kaplan; Giovanni Barosi; Margherita Massa; Alessandra Balduini
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

7.  Consistent up-regulation of Stat3 Independently of Jak2 mutations in a new murine model of essential thrombocythemia.

Authors:  Vitalyi Senyuk; Ciro Roberto Rinaldi; Donglan Li; Francesca Cattaneo; Aleksandra Stojanovic; Fabrizio Pane; Xiaoping Du; Nadim Mahmud; Jerome Dickstein; Giuseppina Nucifora
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

Review 8.  The role of TGFβ in hematopoiesis and myeloid disorders.

Authors:  Alex Bataller; Guillermo Montalban-Bravo; Kelly A Soltysiak; Guillermo Garcia-Manero
Journal:  Leukemia       Date:  2019-02-28       Impact factor: 11.528

Review 9.  The complex regulation of TGF-β in cardiovascular disease.

Authors:  Santiago Redondo; Jorge Navarro-Dorado; Marta Ramajo; Úrsula Medina; Teresa Tejerina
Journal:  Vasc Health Risk Manag       Date:  2012-09-13

10.  Thrombopoietin levels increased in patients with severe acute respiratory syndrome.

Authors:  Mo Yang; Margaret H L Ng; Chi Kong Li; Paul K S Chan; Chang Liu; Jie Yu Ye; Beng H Chong
Journal:  Thromb Res       Date:  2008-03-07       Impact factor: 3.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.